JUNLIAN YIKANG
JUNLIAN YIKANG
Status:
Active
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-09-27 | Bellen | Junlian Yikang investment in Series C - Bellen | 30 M USD |
More informations about "Junlian Yikang"
Junlian Yikang - Crunchbase Investor Profile & Investments
Junlian Yikang - Crunchbase Investor Profile & Investments ... Junlian YikangSee details»
北京君莲益康科技有限责任公司 - 企查查
Sep 9, 2019 企查查为您提供北京君莲益康科技有限责任公司的最新工商信息、公司简介、公司地址、电话号码、招聘信息、信用信息、财务信息、法律诉讼等多维度详细信息查询，让您对北 …See details»
HISTORY, RESTRUCTURING AND CORPORATE STRUCTURE
Beijing Junlian Yikang Equity Investment Partnership (Limited Partnership) (北京君聯益康股權投資合夥企業(有限合夥))(1)(2) 124,404 7.35% SBCVC V PH Company Limited(1)(2) 103,671 …See details»
君联资本
君联资本成立于2001年4月，是中国领先的、专注于早期创业投资以及成长期私募股权投资的专业投资机构。 在二十多年的发展历程中，君联遵循国际通行标准，经历了多支基金的完整管理 …See details»
Legend Capital - Crunchbase Company Profile & Funding
Which industries do these Sub-Organization operate in? Show . Junlian Yikang Subsidiary. Frequently Asked Questions. Edit Frequently Asked Questions Section. Where is Legend …See details»
Changzhou Panda Medical Co., Ltd. - cnverify.com
May 9, 2017 Country:China, Founding date:2017-05-09, Legal representative: Shi Xiufeng, Registered capital:540000RMB, Industry: pharmaceutical manufacturingSee details»
Aohua Endoscopy IPO: a "big customer" turning over and over again
4 days ago Aohua Endoscope stated that, except for Gu Kang and Gu Xiaozhou, none of the company's other directors have been able to act or seek control rights; except for Xiaozhou …See details»
Highlights of the announcement: Megmeet participates in the …
Oct 17, 2024 Guoke Hengtai (301370) announced on the evening of October 17 that Beijing Junlian Yikang Equity Investment Partnership (Limited Partnership) (hereinafter referred to as …See details»
HISTORY, RESTRUCTURING AND CORPORATE STRUCTURE
With, amongst others, High Diamond Limited (高贊有限公司), Beijing Junlian Yikang Equity Investment Partnership (Limited Partnership) (北京君聯益康股權投資合夥企業(有限合夥)), …See details»
Bellen - Web3 Crypto Company Profile, Funding, Valuation, …
A Chinese medical contract research organization.See details»
北京君联益康股权投资合伙企业（有限合伙） - 企查查
May 24, 2025 企查查为您提供北京君联益康股权投资合伙企业（有限合伙）的最新工商信息、公司简介、公司地址、电话号码、招聘信息、信用信息、财务信息、法律诉讼等多维度详细信息 …See details»
成都盛世君联生物技术有限公司
成都盛世君联生物技术有限公司是一家位于成都高新区的生物技术公司,业务涉及抗体发现、药物研发、合成生物学等领域,为全球生物制药企业提供药物发现服务。公司拥有自主构建的多样性 …See details»
HIP20110014e Project Evergreen AP - hkexnews.hk
SUBSTANTIAL SHAREHOLDERS So far as our Directors are aware, immediately following completion of the Share Subdivision and the [REDACTED], assuming no additional Shares are …See details»
北京君联益康股权投资合伙企业（有限合伙） - 天眼查
简介： 北京君联益康股权投资合伙企业（有限合伙），成立于2015年，位于北京市，是一家以从事商务服务业为主的企业。 企业注册资本162142万人民币。通过天眼查大数据分析，北京君 …See details»
Shareholder Junlian Yikang of GKHT Medical Technology …
Feb 14, 2025 Guoke Hengtai (301370.SZ) announcement, the company's shareholder Beijing Junlian Yikang Equity Investment Partnership Enterprise (Limited Partnership... Shareholder …See details»
Bellen Chemistry - CoBee Company Profile & Funding Rounds
Bellen is a contract research organization that develops and commercializes chemical synthesis for the drug manufacturing industry. Business Model: Revenue: $100M. Employees: 201-500. …See details»
Nanovision Technology(Beijing) Co., Ltd - cnverify.com
Pearlvision Company Limited Radiance Visual Company Limited SherpaKC Company Limited Shanghai Hongchun Haowei Medical Device Technology Partnership (Limited Partnership) …See details»
Bellen Chemistry Co., Ltd. - Biotechnology, Pharmaceutical …
The company's recent Series C investment of $30.00M in September 27, 2018, led by Qianhai Fund of Funds, Apricot Capital, CMB International Capital Corporation, Zhongjin Qichen, …See details»
國科恒泰(301370.SZ)：君聯益康累計減持1.1345%股份
格隆匯6月10日丨國科恒泰(301370.SZ)公佈，公司於近日收到君聯益康出具的《關於減持國科恒泰（北京）醫療科技股份有限公司股份計劃實施完成暨減持時間屆滿的告知函》，截至本公告披 …See details»
Junlian Xiang at Toronto Metropolitan University - Rate My …
Professor Junlian Xiang is by far one of the most kind and generous professors out there. She truly cares about the success of the class and gave us bonus marks if you did poorly on the …See details»